Literature DB >> 11980990

Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopes.

Jose Baselga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11980990     DOI： 10.1200/JCO.2002.20.9.2217

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  Conversion of a murine monoclonal antibody A13 targeting epidermal growth factor receptor to a human monoclonal antibody by guided selection.

Authors:  Ki Hwan Chang; Min Soo Kim; Gwang Won Hong; Yong Nam Shin; Se Ho Kim
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

2.  Mechanisms of skin aging induced by EGFR inhibitors.

Authors:  Peter Arne Gerber; Bettina Alexandra Buhren; Holger Schrumpf; Peter Hevezi; Edwin Bölke; Dennis Sohn; Reiner U Jänicke; Viswanath Reddy Belum; Caroline Robert; Mario E Lacouture; Bernhard Homey
Journal:  Support Care Cancer       Date:  2016-05-10       Impact factor: 3.603

Review 3.  Targeted therapies for advanced Ewing sarcoma family of tumors.

Authors:  Yunyun Jiang; Joseph Ludwig; Filip Janku
Journal:  Cancer Treat Rev       Date:  2015-03-27       Impact factor: 12.111

4.  Bronchioloalveolar carcinoma in African Americans.

Authors:  Syed Hasan; Humera Mujahid; Mahmoud Yousef; Reginald Chisholm
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

5.  The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.

Authors:  Boe Sandahl Sørensen; Niels Tørring; Mustafa Vakur Bor; Ebba Nexø
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

6.  A phase II clinical trial of ZD1839 (Iressa) in combination with docetaxel as first-line treatment in patients with advanced breast cancer.

Authors:  Sheri K Dennison; Samuel A Jacobs; John W Wilson; Janell Seeger; Terrence P Cescon; Jane M Raymond; Charles E Geyer; Norman Wolmark; Sandra M Swain
Journal:  Invest New Drugs       Date:  2007-06-12       Impact factor: 3.850

7.  HER2 expression as a potential marker for response to therapy targeted to the EGFR.

Authors:  D R Emlet; R Schwartz; K A Brown; A A Pollice; C A Smith; S E Shackney
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

8.  A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.

Authors:  I Zlobec; T Vuong; S Hayashi; D Haegert; L Tornillo; L Terracciano; A Lugli; J Jass
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

9.  Affinity Maturation of an Epidermal Growth Factor Receptor Targeting Human Monoclonal Antibody ER414 by CDR Mutation.

Authors:  Ki-Hwan Chang; Min-Soo Kim; Gwang-Won Hong; Mi-Sun Seo; Yong-Nam Shin; Se-Ho Kim
Journal:  Immune Netw       Date:  2012-08-31       Impact factor: 6.303

10.  Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice.

Authors:  G Lorch; J L Gilmore; P F Koltz; R M Gonterman; R Laughner; D A Lewis; R L Konger; K S Nadella; R E Toribio; T J Rosol; J Foley
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.